Watch Now: mAbs and ADCs On Demand Event

by Jessica Hogan | April 5, 2023

mAbs Banner

Click HERE to watch the On Demand Event.


Building a Successful mAb Platform using the CHOZN® Cell Lines and UCOE® Technology
Steven Richardson, Technology Consultant, Upstream Bioprocessing

Developing a mAb expression platform is a critical and time-consuming task. The CHOZN® Expression Platform includes a ready-to-use, industry-leading CHO cell line that creates high-producing clones without needing process optimization.

Join us for an introduction to the CHOZN® cell line and how to bring your project from DNA to GMP production. We will also share information on our UCOE® technology, which improves plasmid integration and mAb expression levels to drive higher titers.

ADCs and the Growing Atlas of Bioconjugates
Kaelyn Wilke, Associate Director, ADC & Bioconjugation Services

Deemed “magic bullets” by some in the biotherapeutics community, antibody-drug conjugates (ADCs) chemically link the potency of small-molecule chemotherapies with the selective targeting of monoclonal antibodies (mAbs). Recently, non-traditional ADC components across the small-to-large modality space are used to form novel conjugates and reach new and diverse indications.

In this presentation, we will explore this growing atlas of bioconjugates.

From Discovery to Market Readiness, a CTDMO as an Enabler
Jean François Michel, Head of Commercial Manufacturing, Life Science Services
Jean-Baptiste Noirot-Cosson, Head of Manufacturing Science and Technology, Life Science Services
In early development, biotechs are challenged to move fast while generating data on their lead molecule and its manufacturability. How do you make sure that process data isn’t lost in translation between clinical and commercial manufacturing?
Here we present how biologics contract testing development and manufacturing (CTDMO) can be an enabler for innovators to bring their molecule to market. We’ll discuss the importance of tech transfer for market readiness, the impact of harmonized single-use equipment on faster validation, and our commercial production facility’s capacity and capabilities.

Click HERE to watch the On Demand Event.

Related Posts

Watch on Demand! Biolabs European expansion

BioLabs builds innovation communities around Biotech entrepreneurs providing them with infrastructure, support, and networking to successfully succeed. Hear...

Mirrored disco balls

Bridging the Sponsor – CMO Data Gulf

Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…

Watch on Demand! The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds

Insights on the changes in the biotech VC landscape and tips from an investor perspective for companies fundraising...

Strengthening the CDMO-Sponsor Partnership with Improved Data Sharing and Collaboration

Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous...

Bioprocessing operators in a closed processing CNC space

Are you OPEN to CLOSE your bioprocess?

In this webinar, you will: •Understand the main drivers and benefits of closed processing in biopharma, including facility...

Good Laboratory Practice and the Impact on Start Up Companies

The definition of Good Laboratory Practice (GLP) is given by the Organization for Economic Co-operation and Development (OECD)…

Scroll to Top